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MS: HYPE201506365D/R 
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Abstract 
Transient receptor potential melastatin 7 (TRPM7) is a bi-functional protein comprising a magnesium 
(Mg2+)/cation channel and a kinase domain. We previously demonstrated that vasoactive agents regulate 
vascular TRPM7. Whether TRPM7 plays a role in the pathophysiology of hypertension and associated 
cardiovascular dysfunction is unknown. We studied TRPM7kinase-deficient mice (TRPM7Δkinase) 
(heterozygous for TRPM7kinase) and wildtype (WT) mice infused with Ang II (400 ng/kg/min, 4 weeks). 
TRPM7kinase expression was lower in heart and aorta from TRPM7Δkinase versus WT mice, effects that 
were further reduced by Ang II infusion. Plasma Mg2+ was lower in TRPM7Δkinase versus WT mice in 
basal and stimulated conditions. Ang II increased blood pressure in both strains with exaggerated 
responses in TRPM7Δkinase versus WT groups (p<0.05). Acetylcholine-induced vasorelaxation was 
reduced in Ang II-infused TRPM7Δkinase mice, an effect associated with Akt and eNOS downregulation. 
Vascular VCAM-1 expression was increased in Ang II-infused TRPM7kinase-deficient mice. TRPM7 
kinase targets, calpain and annexin-1, were activated by Ang II in WT but not in TRPM7Δkinase mice. 
Echocardiographic and histopathological analysis demonstrated cardiac hypertrophy and LV dysfunction 
in Ang II-treated groups. In TRPM7kinase-deficient mice, Ang II-induced cardiac functional and 
structural effects were amplified compared with WT counterparts. Our data demonstrate that in 
TRPM7Δkinase mice, Ang II-induced hypertension is exaggerated, cardiac remodelling and LV 
dysfunction are amplified and endothelial function is impaired. These processes are associated with 
hypomagnesemia, blunted TRPM7kinase expression/signaling, eNOS downregulation and pro-
inflammatory vascular responses. Our findings identify TRPM7kinase as a novel player in Ang II-induced 
hypertension and associated vascular and target organ damage. 
 
Key words: Blood pressure, endothelial dysfunction, TRPM, magnesium, signal transduction.  
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Introduction 
The transient receptor potential (TRP) melastatin 7 (TRPM7) cation channel is a member of the TRP ion 
channel superfamily which, together with its homolog TRPM6, has the unique property of possessing a 
cation channel domain coupled to a cytosolic α-type serine/threonine kinase domain that comprises the 
carboxy-terminal region of the protein (hence also termed “chanzyme”) (1, 2). While the channel domain 
regulates transmembrane magnesium (Mg2+) influx, the kinase domain influences downstream signaling 
targets such as annexin-1, calpain, myosin-IIA heavy chain, Ef2-k and PLCγ2 (3-6). The kinase domain 
can also influence TRPM7 channel function (7). TRPM7 regulates many cellular processes including 
Mg2+ homeostasis, cell growth/apoptosis, motility, actin-myosin interaction, differentiation, and 
mechanosensitivity (8-10). Studies in TRPM7-deficient mice indicate that TRPM7 plays an essential role 
in embryonic development, kidney morphogenesis, cardiac function and systemic Mg2+ homeostasis (11-
13). TRPM7 dysfunction has been implicated in numerous pathologies including neurodegenerative 
disorders, cancer and cardiovascular disease (14-18). Although the physiological and pathological 
significance of TRPM7 is becoming increasingly apparent, the biology of TRPM7, particularly in the 
cardiovascular system, still remains elusive.  
We previously demonstrated that TRPM7 is expressed in the vasculature and that it is regulated by 
vasoactive agents, such as bradykinin, aldosterone, endothelin-1, and angiotensin II (Ang II) (19-23). 
Physical factors such as shear stress and flow stimulate TRPM7 activity implicating TRPM7 as a 
mechanotransducer in vascular cells (24, 25). TRPM7 plays an important role in modulating vascular 
smooth muscle cell (VSMC) Mg2+ homeostasis (1, 19-22, 26), a major determinant of VSMC function 
and vascular tone. Experimental evidence indicates that Mg2+ deficiency causes endothelial dysfunction, 
arterial remodeling and hypertension and that normalization of Mg2+ improves vascular function and 
reduces blood pressure (BP) (27).  
Mechanisms regulating vascular Mg2+ in health and disease remain unclear but TRPM7 could be 
important. Aberrant TRPM7 expression/activity may contribute to impaired intracellular free Mg2+ 
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concentration ([Mg2+]i) and VSMC contraction, proliferation, inflammation, and fibrosis, important 
determinants of vascular dysfunction and remodelling in hypertension (28). In support of this 1) pro-
hypertensive factors, such as Ang II and oxidative stress, regulate TRPM7 expression/activity (22, 29), 2) 
vascular TRPM7 is dysfunctional in spontaneously hypertensive rats (30), 3) renal TRPM7 is 
downregulated in aldosterone-infused mice (31), 4) pulsatile atheroprone shear stress stimulates 
endothelial TRPM7 expression (32), 5) TRPM7 is upregulated after renal ischemia (33), and 6) TRPM7 is 
implicated in vascular remodeling and inflammation induced by pressure overload (34). Moreover clinical 
studies showed decreased expression of TRP channels in cerebral vascular tissue from patients after 
hypertensive intracerebral hemorrhage (35). 
The critical importance of TRPM7 is emerging from studies in which TRPM7 gene has been deleted. In 
cells from TRPM7-knockout mice and in cells in which siRNA is targeted to TRPM7, growth is 
abnormal, proliferation is arrested and cells undergo apoptosi  and death (11, 12). In embryonic 
cardiomyocytes in which TRPM7 is disrupted, spontaneous Ca2+ transient firing is reduced with 
associated downregulation of voltage-dependent C 2+ channel (36). At the whole animal level, 
homozygous TRPM7 kinase (Δ kinase) knockout is embryonic lethal, indicating the critical role of 
TRPM7 kinase for normal development (11,12,37). Heterozygous TRPM7kinase mice are viable, but 
exhibit signs of hypomagnesaemia.  
Considering the importance of TRPM7 in the cardiovascular system, we hypothesised that TRPM7 
disruption plays a role in the pathophysiology of hypertension. To address this we induced hypertension 
by Ang II infusion in mice deficient in TRPM7 kinase (TRPM7Δkinase) and investigated BP responses 
and effects on cardiac, renal, and vascular function. In addition, we explored putative molecular 
mechanisms underlying TRPM7kinase-dependent cardiovascular effects.   
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Methods 
Please see supplemental text for detailed methods 
Animals 
Male mice, 3 months of age, mixed background (C57B6 and SV129), were studied including: wildtype 
(TRPM7+/+) mice and mice heterozygous for the deletion of the TRPM7kinase domain (TRPM7Δkinase) 
(12). Homozygous mice were not studied because of embryonic lethality (12). Mice were infused with 
Ang II (osmotic minipumps, 4 weeks). Systolic BP was measured by plethysmography.  
Echocardiography 
Transthoracic echocardiography was performed at the end of the study (Vevo 2100 imaging system with 
40-MHz transducer).  
Vascular function 
Vascular function of small mesenteric resistance arteries was studied by wire myography (38,39). Vessel 
contractility was assessed by concentration-response curves to norepinephrine (NE). Endothelium-
dependent and -independent relaxation was assessed by measuring dilatory responses to acetylcholine 
(ACh) and diethylamine NONOate (DEA-NO) respectively in pre-contracted vessels.  
Vascular structure and mechanics 
Vascular structure and mechanics were studied by pressure myography (38).  
Western Blotting 
Total protein and membrane-enriched fractions were analyzed by immunoblotting. 
Reactive Oxygen Species (ROS) Assessment 
NADPHoxidase-derived O2•- was assessed by lucigenin-enhanced chemiluminescence, hydrogen 
peroxide (H2O2) by Amplex Red, and nitric oxide (NO) by the Nitrate/Nitrite Colorimetric Assay Kit.   
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Statistics 
Data are presented as means±SEM. Groups were compared using one-way ANOVA with Tukey’s 
correction to compensate for multiple testing. p<0.05 was significant. 
Results 
Reduced cardiac and vascular TRPM7kinase expression in TRPM7Δkinase and Ang II-infused 
mice.   
To analyze TRPM7kinase protein expression in mice, we first sought to investigate the specificity of the 
TRPM7kinase antibody. HEK cells overexpressing full length TRPM7 under the control of tetracycline 
(tet) and HEK cells deficient in the kinase domain (Δkinase) were used as we described, (23). Tet-on 
HEK cells with full length TRPM7 showed significant TRPM7 expression, while in Tet-on Δkinase cells, 
protein was undetectable (Fig. 1A). These findings confirmed the specificity of the antibody for 
TRPM7kinase. Using this antibody, we probed for TRPM7kinase in cardiac and vascular tissue in our 
experimental groups. TRPM7kinase expression was reduced ≈ 50% in cardiac and vascular tissue in 
TRPM7Δkinase mice compared to TRPM7+/+ mice, which reflects the heterozygosity of the 
TRPM7Δkinase mice (Figs 1B, 1C). Ang II reduced TRPM7kinase expression in heart and aorta in both 
strains. 
Immunohistochemical analysis demonstrated that in aorta, TRPM7kinase is expressed in both the 
vascular media (vascular smooth muscle cells (VSMC)) and in the endothelium (endothelial cells (EC)) 
(Fig. 1C).  In Ang II-infused mice, TRPM7kinase expression in VSMC and ECs was reduced in WT and 
TRPM7kinase-deficient mice.  
Morphological characteristics and biochemical analysis. 
Body weight was similar between groups (Table 1). Cardiac mass was increased in Ang II-infused 
TRPM7+/+ and TRPM7Δkinase mice versus controls. Ang II-induced cardiac hypertrophy was 
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significantly greater in TRPM7Δkinase mice versus Ang II-infused TRPM7+/+. Renal mass was similar 
between vehicle-infused groups, and no kidney hypertrophy was observed in Ang II-infused group.    
Biochemical analysis is summarized in Table 2. In vehicle-infused mice, plasma Mg2+ levels were lower 
in TRPM7Δkinase than WT mice. Ang II increased plasma Mg2+ in TRPM+/+, but not in TRPM7Δkinase 
mice. Plasma urea levels and urinary albumin-creatinine ratio were increased in Ang II-infused mice, 
reflecting renal dysfunction. Ang II reduced plasma albumin, calcium and chloride levels only in 
TRPM7Δkinase mice. Urine nitrate/nitrite, marker of systemic NO production, was reduced in Ang II-
infused groups versus control counterparts.  
Echocardiography. 
Echocardiography was performed to determine left ventricle (LV) dimensions and function (Table 3). No 
differences in echocardiographic measurements were observed between vehicle infused-groups. LV mass 
and intraventricular septum (IVS) thickness in diastole (d) were increased in Ang II-infused TRPM7+/+ 
mice versus vehicle-infused counterparts. In TRPM7Δkinase mice EF and FS were significantly 
decreased upon Ang II infusion compared to vehicle-infused TRPM7+/+. LV mass, LVIDd, LVID in 
systole (s) and LVPWd were increased in TRPM7Δkinase mice versus vehicle-infused TRPM7+/+. In Ang 
II-infused TRPM7Δkinase mice there was a more pronounced decrease in EF, increase in LV mass and 
LVIDd than in Ang II-infus d controls.   
Cardiac histopathology   
Cardiac hypertrophy was further analyzed histologically using hematoxylin and eosin (Supplemental Fig. 
1A). Hematoxylin-eosin staining revealed that vehicle-infused TRPM7+/+ and TRPM7Δkinase mice had 
similar cardiac morphology with no gross abnormalities. Ang II promoted an increase in heart size in both 
groups, with a greater effect in Ang II-infused TRPM7Δkinase mice, especially in the left ventricle 
(Supplemental Fig. 1B).  
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Cardiac collagen accumulation was assessed by Sirius Red staining (Supplemental Fig. 2A and table 4) 
and interstitial fibrosis was assessed by Masson’s trichrome staining (Supplemental Fig. 2B). Hearts from 
vehicle-infused TRPM7+/+ and TRPM7Δkinase mice did not exhibit collagen deposition nor fibrosis. In 
hearts from Ang II-infused mice there were foci of collagen deposition and interstitial fibrosis (Table 4). 
Perivascular collagen content and fibrosis were increased in Ang II-infused mice versus vehicle-infused 
controls (Supplemental Fig. 2A, 2B).  
Aortic histopathology  
Photomicrographs of Masson’s trichrome-stained cross-sections of thoracic aorta showed that vehicle-
infused TRPM7+/+ and TRPM7Δkinase mice have similar media thickness. Ang II infusion led to a 
significant increase in the media thickness in both groups (Supplemental Fig. 3A, 3B). The thickening of 
the aortic media is evidenced by the distance between each concentric elastic lamina intermingled with 
the smooth muscle cell layers. A pronounced thickening of the perivascular adventitial layer was also 
observed in Ang II-infused groups.  
BP effects of Ang II in TRPM7Δkinase mice 
Figure 2 shows BP in TRPM7+/+ and TRPM7Δkinase mice infused with vehicle or Ang II for 4 weeks. No 
differences in basal BP were observed between vehicle-infused groups. In Ang II-infused TRPM7+/+ 
mice, BP increased gradually over 10 days at which time BP became significantly higher than vehicle-
treated controls. BP remained elevated until the end of the experiment. In Ang II-infused TRPM7Δkinase 
mice, the onset of hypertension was rapid, occurring within 6 days of Ang II infusion. The magnitude of 
BP elevation by Ang II was significantly greater in TRPM7Δkinase mice versus vehicle-infused 
counterparts. 
Effect of Ang II on vascular function in TRPM7Δkinase mice. 
As shown in figure 3A, maximal Ach-induced relaxation was significantly reduced in mesenteric 
resistance arteries from Ang II-infused TRPM7Δkinase versus vehicle-infused TRPM7+/+ mice. 
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Decreased sensitivity to Ach (pD2) was observed in arteries from both Ang II-infused groups (Inset Fig. 
3A). This impairment was specific for endothelium-dependent relaxation since arteries from Ang II-
infused TRPM7+/+ and TRPM7Δkinase mice showed similar relaxation to DEA-NO (NO donor) (Fig. 
3B).  
Contractile responses to NE were similar in vehicle-infused TRPM7+/+ and TRPM7Δkinase mice (Fig. 
3C). Ang II-infused mice displayed increased contraction to NE compared to vehicle-infused 
counterparts. 
Ang II effects on vascular structure. 
Pressurized arteries had comparable lumen diameter at 3 mmHg of intraluminal pressure in all four 
groups (Supplemental Fig. 4A). With a progressive increase of intraluminal pressure, the lumen diameter 
increased to a lesser degree in Ang II-infused versus vehicle-infused TRPM7+/+ mice (Fig. 4A). Media 
cross-sectional area (Supplemental Fig. 4B) and media to lumen ratio (Supplemental Fig. 4C) were 
similar in all groups at intraluminal pressure of 3 mmHg. In response to stepwise increments of 
intraluminal pressure these parameters were not affected by Ang II.  
Vascular mechanics. 
Mesenteric resistance arteries from all groups had comparable strain (Fig. 4A) at an intraluminal pressure 
of 3 mmHg. In arteries from vehicle-infused groups, TRPM7Δkinase mice showed decreased stress-
pressure (Fig. 4B) in response to stepwise increments of intraluminal pressure compared to TRPM7+/+. In 
both Ang II treated groups, artery deformation and stress-pressure in response to stepwise increments of 
intraluminal pressure, were lower than in vehicle-infused TRPM7+/+ mice. Ang II evoked a shift to the left 
in the stress-strain curve to an equal extent in both groups, indicating that vessels from both of the Ang II-
infused groups are stiffer than vehicle-infused counterparts (Fig. 4C).  
Activation of vascular eNOS, Akt and caveolin-1  
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To investigate putative molecular mechanism underlying endothelial dysfunction in Ang II-infused 
TRPM7Δkinase mice, we examined vascular expression and phosphorylation of eNOS and its upstream 
regulator Akt in Ang II-infused TRPM7+/+ and TRPM7Δkinase mice. As demonstrated in figure 5A basal 
eNOS was similar in TRPM7+/+ and TRPM7Δkinase mice. However, in Ang II-infused TRPM7kinase-
deficient mice, eNOS levels were significantly reduced compared with vehicle- and Ang II-infused 
TRPM7+/+ mice. Phosphorylation of eNOS (serine 1177, activation site) was significantly decreased in 
Ang II-infused TRPM7Δkinase mice versus vehicle-treated mice (Fig. 5B). Akt was phosphorylated in 
Ang II-infused TRPM7+/+ but not in Ang II-infused TRPM7Δkinase mice (Fig. 5C). In membrane-
enriched fractions, expression of eNOS was lower and that of caveolin-1 was higher in Ang II-infused 
TRPM7Δkinase mice versus control counterparts (Supplemental Fig. 5A, 5B).  
Ang II effects on TRPM7 targets, mitogen-activated protein (MAP) kinases and pro-inflammatory 
mediators in arteries from TRPM7+/+ and TRPM7∆kinase mice.  
Upon activation, calpain and annexin-1, TRPM7 kinase downstream targets, translocate to the plasma 
membrane. The content of calpain and annexin in membrane-enriched fractions was evaluated as a 
functional index of TRPM7. As shown in figure 6 Ang II increased calpain and annexin-1 membrane 
content in arteries from TRPM7+/+ mice, but failed to elicit any response in TRPM7∆kinase mice.  
Expression of the VCAM-1, an adhesion molecule induced by inflammatory mediators, was significantly 
increased in aorta from TRPM7+/- mice compared to other groups (Fig. 7A).  
At the molecular level, MAP kinases play a key role in vascular regulation by Ang II. We evaluated 
activation of vascular ERK1/2 and JNK in Ang II-infused TRPM7+/+ and TRPM7+/- mice. As shown in 
figure 7B and supplemental figure 6 Ang II significantly increased phosphorylation of ERK1/2 and JNK 
in arteries from TRPM7+/+ mice. Similar responses were observed in TRPM7∆kinase suggesting that 
TRPM7 kinase is not critically involved in MAP kinase activation by Ang II.  
Ang II effects on systemic and vascular ROS in TRPM7+/+ and TRPM7∆kinase mice. 
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The role of ROS generation by Ang II was analyzed in TRPM7+/+ and TRPM7∆kinase mice. Plasma H2O2 
concentration was similar between vehicle-infused TRPM7+/+ and TRPM7∆kinase mice. Ang II had no 
significant effect on plasma H2O2 in either group (supplemental Fig. 7A and 5B). NADPH-dependent 
superoxide anion generation was measured in aortic homogenates by lucigenin-enhanced 
chemiluminescence and showed similar responses in TRPM7+/+ and TRPM7∆kinase mice (supplemental 
Fig. 7C). Translocation of the Nox cytosolic subunit p47phox from the cytosol to membrane was 
evaluated as an index of oxidase activation.  Expression of p47phox in membrane-enriched fractions was 
similar between groups (supplemental Fig. 7D).  
Discussion 
This study demonstrates a distinct cardiovascular phenotype in Ang II-infused TRPM7∆kinase mice 
characterised by severe hypertension, exaggerated cardiac hypertrophy, worsening of left ventricular 
dysfunction and persistent hypomagnesemia compared with wildtype counterparts. Associated with these 
changes is impaired endothelial function, downregulation of eNOS and blunted signaling through 
TRPM7kinase, without effect on MAP kinases or redox status. Our findings identify TRPM7kinase as a 
novel player in the regulation of BP and cardiovascular function and indicate that TRPM7kinase 
perturbations may be important in the pathophysiology of Ang II-induced hypertension and associated 
vascular and target organ damage (Fig. 8). Cardiac and vascular expression of TRPM7kinase was 
significantly downregulated by Ang II in WT and TRPM7∆kinase mice indicating an important negative 
interaction between these systems. 
Phenotypically TRPM7∆kinase mice in basal conditions were similar to wildtype controls, except for 
significant hypomagnesemia, likely due to reduced intestinal Mg2+ absorption and increased renal Mg2+ 
wasting, since TRPM7 and its homologue TRPM6 are major Mg2+ transporters in epithelial cells in the 
gastrointestinal tract and kidneys as we reported (1-3, 12, 13). Similar to other knockout models used to 
interrogate the pathophysiology of hypertension, a pathological phenotype was only unmasked when 
TRPM7∆kinase mice were challenged with Ang II. In mice deficient in TRPM7kinase, Ang II-induced 
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hypertension was exaggerated and target organ damage was amplified. These phenomena were associated 
with pronounced endothelial dysfunction and blunted TRPM7kinase signaling through Akt, calpain and 
annexin-1. The relationship between reduced TRPM7 expression/activity, hypomagnesemia and BP has 
previously been suggested in experimental models of hypertension (16, 27, 40-42). Here we advance this 
concept and suggest that TRPM7kinase fine-tunes Ang II actions, because when it is downregulated, Ang 
II effects were augmented. This is supported by our previous findings in another mouse model with 
hereditary hypomagnesemia and associated downregulation of TRPM7 (42). While exact molecular 
mechanisms underlying the regulatory role of TRPM7 are still unclear, dampened TRPM7 signaling, as 
demonstrated here, may be important. However, we cannot exclude the possibility that some of the 
observed effects in our study may also relate to altered Mg2+ homeostasis and hypomagnesemia, 
especially since our previous studies demonstrated that alterations in TRPM7∆kinase mice were 
ameliorated by Mg2+ supplementation (12). 
TRPM7 plays an important role in the regulation and function of endothelial cells as demonstrated in 
human umbilical vein endothelial cells, where TRPM7 deficiency leads to altered growth and migration 
(43). In our in vivo study here, endothelial function was not significantly altered by Ang II in wildtype 
mice but was markedly impaired in Ang II-infused TRPM7∆kinase mice as evidenced by reduced 
endothelium-dependent vasodilation. Reasons why Ang II did not influence endothelial function, or ROS 
production, in wildtype mice, as expected, are unclear but may relate, in part, to the fact that the mice 
studied here were of mixed genetic background, where responses to vasoactive agents are variable.  
Decreased acetylcholine-induced vasorelaxation in Ang II-infused TRPM7∆kinase mice was associated 
with decreased eNOS phosphorylation and Akt activation and increased membrane-associated caveolin-1. 
Since eNOS is negatively modulated by caveolin-1, upregulation of caveolin-1 may reduce eNOS 
bioactivity, as previously reported (44,45). In addition blunted effects of Ang II on Akt, an upstream 
regulator of eNOS, may play a role in reduced eNOS activation in TRPM7∆kinase mice. These molecular 
processes likely contribute to dampened eNOS phosphorylation and NO generation with consequent 
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endothelial dysfunction and reduced vasorelaxation, important determinants of BP elevation.  It is also 
possible that hypomagnesemia in TRPM7∆kinase mice may influence endothelial function, since 
decreased [Mg2+]i enhances agonist-stimulated vasoconstriction and impairs vasodilation, while increased 
[Mg2+]i is associated with vasorelaxation. These effects may occur through Mg2+ interactions with Ca2+, or 
through eNOS modulation by Mg2+ (46).  
One of the earliest indicators of endothelial inflammation is expression of adhesion  molecules, such as 
VCAM-1, which promotes leukocyte adhesion to the endothelium and migration of macrophages through 
the vascular media. Increased VCAM expression has been demonstrated in atherosclerosis and 
hypertension and is closely associated with vascular inflammation through processes that involve 
activation of MAP kinases and oxidative stress. In TRPM7kinase-deficient mice, Ang II induced a 
significant increase in VCAM-1 expression. Molecular mechanisms underlying the inflammatory 
response are unclear, but may relate to decreased activation of TRPM7kinase targets, annexin-1 and 
calpain, which have anti-inflammatory and pro-migratory functions respectively (3, 47). Reduced 
annexin-1 expression and increased inflammation have been demonstrated in aortas from 
hypomagnesemic mice (40). We recently demonstrated that the TRPM7kinase domain, but not the 
TRPM7 channel domain, regulates annexin-1 and calpain signalling (23). The inflammatory and 
endothelial responses observed in our study appear to be independent of changes in oxidative stress or 
redox-sensitive MAP kinase signaling, because TRPM7kinase-deficiency had little impact on Ang II-
induced phosphor lation of ERK1/2 and JNK. 
The hypertensive vascular phenotype is characterised not only by endothelial dysfunction, but also by 
vascular remodeling (28). Previous studies demonstrated a role for TRPM7 and Mg2+ in vascular 
hypertrophy in hypertension (28,41). Here we show that in Ang II-treated mice, lumen diameter was 
reduced and the stress-strain relationship had a leftward shift compared with controls. Effects were 
similar in TRPM7+/+ and TRPM7∆kinase mice indicating that remodeling and altered mechanics 
(increased stiffness) induced by Ang II are independent of TRPM7 kinase. These findings are in contrast 
Fo
r H
yp
ert
en
sio
n P
ee
r R
ev
iew
. D
o n
ot 
dis
trib
ute
.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
De
str
oy
 af
ter
 us
e.
15 
 
to those for endothelial dysfunction, which had a significant TRPM7 component, suggesting that TRPM7 
kinase may be more important in endothelial than vascular smooth muscle cell regulation, at least in 3 
month-old mice. Whether vascular structural changes become more apparent with aging in 
TRPM7∆kinase mice awaits confirmation. 
TRPM7 has also been implicated in cardiac regulation and growth, since disturbed TRPM7 activity leads 
to abnormal cardiogenesis and impaired ventricular function (36, 37). In rat cardiomyocytes increased 
TRPM7 activity was involved in Ang II-induced cardiac fibrosis (48). In mouse heart and aorta, 
upregulation of TRPM7 channels by Ang II was associated with a proliferative phenotype of ascending 
aortic smooth muscle cells, an effect that was mediated through TRPM7 suppression of Pyk2-ERK1/2-
Elk-1 signaling (49). Moreover cardiac arrhythmias have been linked to both up- and down-regulation of 
TRPM7 (35, 36). In our study, decreased TRPM7kinase activity was associated with exaggerated cardiac 
hypertrophy and pronounced left ventricular dysfunction in Ang II-infused mice. While this might be an 
adaptive response secondary to severe hypertension, it is also possible that decreased myocardial 
TRPM7kinase activity itself may contribute to structural and functional cardiac changes.  
In conclusion, we show that in heterozygous TRPM7∆kinase mice Ang II induces an exaggerated 
hypertensive response, pronounced cardiac hypertrophy, and worsening of left ventricular function. 
Associated with these changes is endothelial dysfunction and inflammation, processes linked to blunted 
TRPM7kinase signaling and eNOS downregulation. Vascular remodeling and vascular MAPK activation, 
typically associated with Ang II-induced hypertension, were not influenced by TRPM7kinase deficiency. 
These observations indicate that TRPM7kinase differentially regulates vascular function in hypertension, 
with a primary target being the endothelium. Our findings identify TRPM7kinase as a modulator of BP 
regulation, which when downregulated promotes severe hypertension and worsening of cardiovascular 
function. Moreover, we show that Ang II is a negative regulator of TRPM7. Taken together this study 
defines a novel TRPM7kinase-sensitive mechanism involved in Ang II-induced hypertension and target 
organ damage. 
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Perspectives 
Alterations in electrolyte status and ion transporters have been implicated in the pathophysiology of 
hypertension. While there is extensive data on calcium, sodium and potassium in hypertension, there is a 
paucity of information about magnesium and its transporters. Here we identify TRPM7, a 
magnesium/cation channel with kinase activity, as a regulator of magnesium homeostasis and modulator 
of BP regulation. Altered activity of TRPM7, particularly the kinase domain, is associated with 
hypomagnesemia, endothelial dysfunction, vascular inflammation, cardiac dysfunction and exaggerated 
pressor responses to Ang II. Our findings identify TRPM7kinase and its downstream signaling pathways 
as a novel paradigm in Ang II-induced hypertension. Perturbed activation of TRPM7kinase may be an 
important mechanism linking hypomagnesemia and cardiovascular injury in hypertension, 
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Novelty and Significance 
What Is New? 
• TRPM7, a unique Mg2+ transporter with kinase activity, influences vascular function and 
blood pressure in Ang II-induced hypertension. 
• TRPM7 kinase deficiency leads to exaggerated hypertension with associated eNOS 
downregulation and amplified endothelial dysfunction. 
• TRPM7 kinase/eNOS is a novel system through which Ang II signals. 
What Is Relevant? 
• Clinical hypertension is associated with perturbed Mg2+ homeostasis and vascular 
dysfunction, possibly through TRPM7 dysfunction.  
• Targeting TRPM7 kinase may have potential as a novel therapeutic target in hypertension.  
Summary 
TRPM7 kinase regulates vascular function in hypertension, with a primary target being the 
endothelium. TRPM7 kinase may have vasoprotective functions, which when dysregulated 
contributes to endothelial dysfunction, vascular inflammation and hypertension. We identify a 
novel TRPM7 kinase-sensitive mechanism in Ang II-induced hypertension. 
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Figure legends 
Figure 1. TRPM7kinase expression in heart and aorta of TRPM7+/+ and TRPM7∆kinase 
mice. A. Validation of TRPM7kinase antibody (Epitomics; # 3828-1). TRPM7 kinase expression 
in HEK cells expressing TRPM7 full length protein (WT) and TRPM7 lacking the kinase domain 
(Δ kinase) under the control of tetracycline. Cells deficient in TRPM7kinase failed to express the 
protein. B. Hearts were isolated from TRPM7+/+ and TRPM7∆kinase mice infused with vehicle 
or Ang II. Protein expression of TRPM7kinase was analyzed as a ratio to β-actin. Upper panels, 
representative immunoblots of TRPM7 and β-actin. Bar graphs represent mean ± SEM of 9-11 
mice per group. *p<0.05 vs vehicle-infused TRPM7+/+. C. TRPM7kinase expression was 
analyzed in aortas from vehicle and Ang II-infused mice. Panels are representative 
photomicrographs of paraffin-embedded aortic sections processed for immunohistochemistry of 
TRPM7kinase, with original magnification of x100. Data were obtained from 5 mice/group. 
Stars (*) and arrows (↑) indicate the presence of TRPM7kinase in vascular media and 
endothelium respectively.  
Figure 2. Systolic blood pressure (BP) in TRPM7+/+ and TRPM7+/- mice infused with Ang 
II. TRPM7+/+ and TRPM7+/- mice were infused with vehicle or Ang II (400 ng/Kg/min., osmotic 
minipumps; 4 weeks). BP was measured weekly for 4 weeks (W) by tail-cuff plethysmography. 
Line graphs represent mean ± SEM of 10-19 mice per group. *p<0.05 vs vehicle-infused 
counterparts: +p<0.05 vs Ang II-infused TRPM7+/+. 
Figure 3. Functional responses in mesenteric arteries from Ang II-infused TRPM7+/+ and 
TRPM7+/- mice. Mesenteric arteries were isolated from TRPM7+/+ and TRPM7+/- mice infused 
with vehicle or Ang II. Concentration-response curves to cumulative concentrations of 
acetylcholine (Ach, 10-9- 3 x 10-5 M) (A), diethylamine NONOate (DEA-NO, 10-9- 3 x 10-5 M) 
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(B), and norepinephrine (NE, 10-9- 3 x 10-5 M) (C) were analyzed in vessels mounted on wire 
myographs. Line graphs represent mean ± SEM of 7- 17 mice per group. Inset (A) shows the 
sensitivity to Ach expressed by pD2 values. *p<0.05 vs vehicle-infused counterparts: +p<0.05 vs 
Ang II-infused TRPM7+/+. 
Figure 4. Mechanical properties in mesenteric resistance arteries from Ang II-infused mice. 
Mesenteric resistance arteries were isolated from TRPM7+/+ and TRPM7+/- mice infused with 
vehicle or Ang II. Strain (A), Stress (B), and Stress-strain relationship curves (C) were analyzed 
by pressure myography. Mesenteric arteries were incubated in 0 Ca2+-physiological salt solution 
containing 10 mmol/L EGTA and were subjected to increasing levels of intraluminal pressure. 
Line graphs represent mean ± SEM of 5 mice per group. *p<0.05 vs vehicle-infused 
counterparts; †p<0.05 vehicle-infused TRPM7+/- 
Figure 5. Ang II effects on expression and phosphorylation of eNOS and Akt in aorta from 
TRPM7+/+ and TRPM7+/- mice. Representative immunoblots and bar graphs of eNOS content 
(A), eNOS (B) and Akt (C) phosphorylation in vessels from vehicle- and Ang II-infused 
TRPM7+/+ and TRPM7+/- mice. Levels of total eNOS, phospho eNOS and phospho Akt are 
expressed relative to expression of  actin. Results are presented as mean ±SEM of 8-9 mice 
per group. *p<0.05 vs vehicle-treated groups; + p<0.05 vs Ang II-infused TRPM7+/+ mice. 
Figure 6. Expression of TRPM7 kinase targets calpain and annexin-1 in membrane-
enriched fractions of mesenteric arteries from Ang II-infused TRPM7+/+ and 
TRPM7∆kinase mice. Mesenteric arteries were isolated from TRPM7+/+ and TRPM7∆kinase 
mice infused with vehicle or Ang II. Protein content of calpain (A) and annexin-1 (B) was 
measured in membrane-enriched fractions. Data are presented as the expression of calpain or 
annexin-1 relative to the expression of β-actin. Upper panels, representative immunoblots of 
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calpain, annexin-1 and α actin. Results are presented as mean ±SEM of 6-9 mice per group. 
*p<0.05 vs vehicle-infused TRPM7+/+. 
Figure 7. Expression of VCAM-1 and ERK1/2 in vessels from Ang II-infused TRPM7+/+ 
and TRPM7∆kinase mice. Aortas were isolated from TRPM7+/+ and TRPM7∆kinase mice 
infused with vehicle or Ang II. (A) Upper panels, representative immunoblots of VCAM-1 and 
β-actin. Data are presented as the expression of VCAM-1 relative to the expression of β-actin. 
(B) Phosphorylation levels of ERK1/2 are presented relative to expression of β-actin. Upper 
panels, representative immunoblots of phospho-ERK1/2 and β-actin. Results are presented as 
mean ±SEM of 5-9 mice per group. *p<0.05 vs vehicle infused counterparts; +p<0.05 vs Ang II-
infused TRPM7+/+. 
Figure 8. Possible molecular mechanisms whereby TRPM7 kinase deficiency amplifies Ang 
II cardiovascular and blood pressure (BP) effects. Blunted TRPM7 kinase signaling by Ang II 
through its G protein-coupled receptor is associated with reduced activation of TRPM7 kinase 
downstream targets, including Akt, calpain and annexin-1, leading to vascular and cardiac 
dysfunction and amplified increase in BP. These processes may also be influenced by reduced 
intracellular Mg2+, possibly due to decreased transmembrane Mg2+ transport as a consequence of 
TRPM7 kinase downregulation (as we previously demonstrated (1)). (–) denotes inhibitory 
effect. Dashed lines are possible pathways. 
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Table 1. Body weight, kidney and heart mass of vehicle and Ang II-infused TRPM7+/+ and 
TRPM7∆kinase mice. 
 
TRPM7+/+ and TRPM7∆kinase mice were infused with vehicle or Ang II (400 ng/Kg/min, 4 
weeks). Results are mean ± SEM. n=6-16 mice per group. Body weight (BW), heart mass (HM), 
kidney mass (KM). *p<0.05 versus vehicle counterparts; †p<0.05 versus Ang II-infused 
TRPM7+/+. 
 
  
 
 
Morphological 
Parameter  
TRPM7+/+ 
      vehicle 
TRPM7+/+ 
        Ang II 
 
TRPM7∆kinase 
vehicle 
 
TRPM7∆kinase
Ang II 
 
BW (g) 24.8 ± 0.7 25.5 ± 1.0 23.4 ± 0.7 24.2 ± 1.0 
HM (mg)/BW(g) 4.4 ± 0.1 5.4 ± 0.1* 4.5 ± 0.1 5.8 ± 0.1*† 
KM (mg)/BW(g) 6.1 ± 0.2 5.8 ± 0.1 6.2 ± 0.1 
 
6.2 ± 0.1 
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Table 2. Plasma and urine profile in vehicle- and Ang II- infused TRPM7+/+ and 
TRPM7∆kinase mice. 
TRPM7+/+ and TRPM7∆kinase mice were infused with vehicle or Ang II (400 ng/Kg/min, 4 
weeks). Results are mean ± SEM. n=6-16 mice per group. *p<0.05 versus vehicle-treated 
counterparts. †p<0.05 versus Ang II-infused TRPM7+/+. ‡p<0.05 versus vehicle-treated 
TRPM7+/+ 
 
Plasma 
TRPM7+/+ 
     vehicle 
  
TRPM7+/+
            Ang II 
 
TRPM7∆kinase  
vehicle 
 
TRPM7∆kinase 
Ang II 
 
Total protein 44.1 ± 0.7 
 
41.4 ± 0.9 * 43.2 ± 0.9 39.8 ±1.2 * 
Albumin 6.0 ± 0.4 5.2 ± 0.5 6.2 ± 0.7 4.4 ± 0.3 * 
 
Cholesterol 2.3 ± 0.07 2.4 ± 0.09 2.2 ± 0.06 2.2 ± 0.07 
 
Triglycerides 1.5 ± 0.1 1.2 ± 0.1 1.3 ± 0.1 1.9 ± 0.4 
 
Glucose 11.2 ± 0.5 11.2 ± 0.4 10.5 ± 0.5 10.5 ± 0.6 
 
Urea 7.9 ± 0.2 11.2 ± 0.7 * 7.9 ± 0.4 10.6 ± 0.5 * 
 
Creatinine 14.9 ± 0.9 14.0 ± 0.8 13.0 ± 1.3 12.3 ± 1.0 
 
Calcium 1.51 ± 0.04 1.55 ± 0.06 1.46 ± 0.06 1.28 ± 0.08 * 
 
Chloride 96.8 ± 1.2 92.8 ± 1.9 95.0 ± 1.2 88.7 ± 2.4 * 
 
Phosphorus 1.2 ± 0.04 1.2 ± 0.07 1.1 ± 0.07 1.2 ± 0.06 
 
Bicarbonate 19.1 ± 0.4 26.5 ± 0.5 20.0 ± 1.1 20.9 ± 1.7 
 
Magnesium 0.65 ± 0.02 0.74 ± 0.04* 0.60 ± 0.01‡ 0.64 ± 0.02† 
 
Urine     
Albumin:creatinine 
ratio (µg/mg) 
25 ± 6 394 ± 99* 47 ± 11 449 ± 118* 
Nitric oxide (µM) 3.7 ± 0.2 3.0 ± 0.2* 3.9 ± 0.2 3.2 ± 0.1* 
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Table 3. Echocardiographic measurements from M-mode images of vehicle- and Ang II- 
infused TRPM7+/+ and TRPM7∆kinase mice. 
 
 
Echocardiographic 
Parameter   
TRPM7+/+ 
   vehicle 
 
TRPM7+/+ 
     Ang II 
 
TRPM7∆kinase
vehicle 
TRPM7∆kinase
Ang II 
 
EF (%) 49.9 ± 5.5 43.6 ± 7.2 42.8 ± 3.1 22.9 ± 3.7 *† 
     
FS (%) 25.1 ± 3.3 19.8 ± 4.3 21.6 ± 1.7 10.5 ± 1.9 * 
 
LV mass (mg) 89.9 ± 3.4 127.1 ± 10.2 * 105.7 ± 5.9 160.9 ± 8.3 *† 
     
IVS; d (mm) 0.77 ± 0.06 1.03 ± 0.03 * 0.89 ± 0.04 0.94 ± 0.04 
 
LVID; d (mm) 3.6 ± 0.07 3.6 ± 0.18 3.6 ± 0.10 4.13 ± 0.15 *† 
 
 
LVID; s (mm) 
 
2.7 ± 0.1 
 
3.1 ± 0.2 
 
2.9 ± 0.1 
 
3.7 ± 0.2 * 
 
 
LVPW; d (mm) 
 
0.76 ± 0.04 
 
0.9 ± 0.03 
 
0.79 ± 0.05 
 
0.96 ± 0.05 * 
 
 
Heart rate  
(bpm) 
 
 
501 ± 20 
 
472 ± 15 
 
455 ± 13 
 
474 ± 23 
 
TRPM7+/+ and TRPM7∆kinase mice were infused with vehicle or Ang II (400 ng/Kg/min., 
osmotic minipum s, 4 weeks). EF = Ejection fraction, FS = Fractional shortening, LV= Left 
ventricle, IVS = Interventricular septum, LVID = Left ventricle internal diameter, LVPW= Left 
ventricle posterior wall, d= in diastole, s= in systole, bpm= beats per minute. Results are mean ± 
SEM. n=5-10 mice per group. *p<0.05 vs vehicle-treated counterparts; †p<0.05 vs Ang II-
infused TRPM7+/+. 
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Table 4. Scores for collagen accumulation and fibrosis of vehicle- and Ang II- infused 
TRPM7+/+ and TRPM7∆kinase mice. 
 
Hearts were isolated from TRPM7+/+ and TRPM7∆kinase mice infused with vehicle or Ang II 
(400 ng/Kg/min., osmotic minipumps, 4 weeks). Paraffin-embedded of heart sections were 
processed for Sirius Red (collagen) and Masson’s trichrome (fibrosis). Staining for both collagen 
content and fibrosis were scored according to the following: – indicates intact; +, mild, ++, 
moderate, +++, severe. Values are numbers of mice displaying collagen deposition or fibrosis. 
n= 8-9 mice per group.  
 
 
 
 
Sirius Red 
    ______________________ 
Masson’s Trichrome 
______________________ 
 - + ++ +++ - + ++ +++ 
Experimental Group         
          
TRPM7+/+ Vehicle 
 
8 0 0 0 8 0 0 0 
TRPM7+/+ Ang II 
 
0 2 4 1 0 1 4 2 
TRPM7∆kinase Vehicle  
 
9 0 0 0 9 0 0 0 
TRPM7∆kinase Ang II 0 2 3 2 0 1 5 2 
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Methods 
Animals 
The study was approved by the Animal Ethics Committee of the Ottawa Hospital Research 
Institute, University of Ottawa and carried out according to the recommendations of the 
Canadian Council for Animal Care. Male, 3 month old wild type (TRPM7
+/+
) mice (C57BL/6J 
and SV129 background) and mice heterozygous for the deletion of the TRPM7kinase domain 
(TRPM7∆kinase), generated by the gene-targeting vector technique (1) were maintained in 
controlled room temperature (25°C) with a 12-h light/dark cycle and had free access to food and 
water. At 8 weeks of age, mice were infused with Ang II (400 ng/Kg/min) by osmotic 
minipumps for 4 weeks. Vehicle (saline)-infused mice were used as a control group. Systolic 
blood pressure (BP) was measured by tail-cuff plethysmography. Basal BP was measured on 3 
different occasions before minipumps were surgically implanted in mice. After receiving the 
minipumps, BP was measured 1-2 times weekly. Spot urine samples were obtained a day prior to 
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sacrifice. At the end of the study, mice were killed by decapitation under anesthesia and 
mesenteric arteries, aorta, heart and blood samples collected for analysis. 
Genotyping of TRPM7
+/+
 and TRPM7∆kinase mice  
A small piece of mouse ear was excised and DNA was extracted with a 100 l of tissue extractor 
plus 25 l of tissue preparation solution (REDExtract-N-AmpTM Tissue PCR Kit, Sigma 
XNATR-1KT). Samples were incubated at room temperature for 10 minutes and then heated at 
98 °C for 3 minutes, following by the addition of 100 μl of neutralizer. Samples were spun down 
and the supernatant obtained was kept at -20
o
C for further PCR reaction. 4 μl of supernatant was 
used as a template in a 20 μl PCR reaction mix. Primers used to detect TRPM7kinase deletion 
(5’ tgc gag gcc aga ggc cac ttg tgt agc 3’; and : 5’ tgc gag gcc aga ggc cac ttg tgt agc 3’) were 
designed to amplify the neighboring sequence regions of TRPM7kinase domain. Therefore, only 
in the absence of TRPM7kinase domain these primers were able to amplify the designated 
template during the PCR cycle specified. For this reason, when using these specificTRPM7 
kinase primer set for genotyping TRPM7
+/+
 mice, these samples do not show any product 
amplification since the extension time in our PCR conditions do not allow amplification of such 
a large sequence (TRPM7 plus neighbor sequence).   
To guarantee that the absence of PCR bands with these primers were truly TRPM7
+/+
 mice and 
not a result obtained due to a poor DNA extraction and/or PCR performance, a control primer set 
(5’ aaa tct tag gct ggt aga cag tg 3’; and 5’ ctt atc tct caa gcc aat tta gga g 3’) independent of 
TRPM7kinase deletion was generated to accurately interpret the data. Therefore with the control 
primer set both TRPM7
+/+
 and TRPM7∆kinase samples must show DNA amplification. PCR 
protocol was as following: 1 cycle of 94
o
C (heat start), and 35 cycles of: 10 sec at 94
o 
C 
(denaturation), 30 sec at 62
o 
C (annealing), 2 min at 68
o 
C (extension). One final cycle of 5 min 
at 68
o 
C was performed, following by a hold on temperature of 4
o 
C. Agarose gel electrophoresis 
was used for visualizing the PCR products.  
Validation of TRPM7kinase antibody in human embryonic kidney (HEK) cells expressing 
full length TRPM7 and in HEK cells deficient in TRPM7 mutant ( kinase)  
Human TRPM7 WT and TRPM7 lacking a kinase domain (Δ kinase) cDNA cloning and the 
establishing of stable inducible expression of the corresponding proteins in HEK-293 T-Rex cells 
(Invitrogen) have been previously described (2). The stably transfected 293-HEK cells 
(expressing WT hTRPM7 and hTRPM7 Δ kinase under tetracycline control) were grown in in 
Dulbecco's Modified Eagle Medium (DMEM) containing 10% fetal bovine serum (FBS), 5 
µg/ml Blasticidin S and 0.4 mg/ml Zeocin. Cells were grown in culture dishes treated with poly-
Lysine (Sigma, P4832) in order to guarantee cell adherence once TRPM7 expression is induced 
upon addition of tetracycline. Briefly, to induce TRPM7 expression, cells were grown in the 
culture medium described above containing 1 µg/ml tetracycline for 24h. In the following day, 
cells were placed on starvation medium (DMEM containing 5 µg/ml Blasticidin S, 0.4 mg/ml 
Zeocin) and 1 µg/ml tetracycline overnight. Analysis of TRPM7 expression was performed by 
Western blotting using TRPM7 antibody (Epitomics Abcam, Rabbit mAb # 3828-1) (described 
below) in control cells (without tetracycline treatment) and in cells exposed to tetracycline to 
induce gene expression (48h).  
Biochemical analysis 
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Plasma was collected immediately following sacrifice and kept at -80°C until further analysis. 
Electrolyte, cholesterol, urea, glucose, creatinine, and protein concentrations were determined 
using an automated analyzer (Beckman Coulter AU5800) by IDEXX Laboratories (Ontario, 
Canada).  
Urinary nitric oxide measurement 
Spot urine was kept at -80°C until further analysis. Total nitrate/nitrite levels were measured in 
the urine as nitric oxide metabolites using the Nitrate/Nitrite Colorimetric Assay Kit (Cayman 
Chemical, Ann Arbor, USA). 
Urinary Albumin and Creatinine measurement 
Assessment of albumin (µg/mL) and creatinine (mg/mL) excretion was performed in urine 
samples with commercial kits (Albuwell M and Creatinine Companion, Exocell) according to the 
manufacturer’s instructions. Results were expressed as albumin:creatinine ratio (ACR). 
Echocardiography 
Cardiac geometry and function were performed using a Vevo 2100 imaging system with a 40-
MHz transducer. Vehicle and Ang II-infused TRPM7
+/+
 and TRPM7∆kinase mice were analyzed 
at the end of the study (25-27 days following Ang II infusion). Mice were lightly sedated by 
continuous gas inhalation (isoflurane, 1.5-2%) throughout the examination. Mice were secured in 
the supine position on a warming pad, the chest hair was shaved, and a warmed echo gel was 
placed on the shaved chest. Echo images were downloaded afterwards and analyzed offline using 
the Vevo 2100 software. 7 beats were measured for each mouse and averaged for the 
interpretation of any given measurements. For all the measurements shown, the hearts were 
examined in M-mode in the parasternal long axis view. All calculated parameters were 
automatically computed by the Vevo 2100 standard measurement package as previously reported 
(3).  
Histological analyses 
For histological and immunohistochemical analyses, the heart and aorta were fixed in 4 % 
paraformaldehyde and processed for paraffin embedding. Sections (5 µm thick) were stained 
with Sirius Red and Masson’s Trichrome. Hematoxylin and eosin staining was performed for LV 
wall analysis as well as heart’s gross morphology. For the morphometric analysis in cross-
sections of heart, the left ventricle wall was measured in three regions and the values were 
averaged. Sirius red staining was performed to examine collagen deposition and Masson’s 
trichrome to determine fibrosis.  
For morphometric analysis in cross-sections of aorta, wall thickness was measured in four 
regions and the values were averaged. For immunohistochemical staining in aorta sections, heat-
induced epitope retrieval was performed at 110
o
 C for 12 min with tris-EDTA buffer (pH 9.0). 
To localize TRPM7, anti-TRPM7-C-terminal (#135817, Abcam, Cambridge, UK) primary 
antibody (dilution 1/50, rabbit) was used. The specificity of the staining was determined upon 
absence of immunoreactivity when the primary antibody was omitted.  
Wire myography to assess vascular function 
Vascular function in second order branches of mesenteric resistance arteries were studied with a 
wire myograph (DMT, Danish Myo Technology, Denmark) as previously described (4). 
Mesenteric resistance arteries were placed  in Krebs Henseleit solution (mM: 118 NaCl, 4.65 
KCl, 1.18 MgSO4, 1.18 KH2PO4, 25 NaHCO3, 2.5 CaCl2, 0.026 EDTA, and 5.5 glucose) under a 
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dissecting microscopy, carefully cleaned of connective tissue, and second order branches 
(corresponding with resistance arteries) were isolated and mounted. Arterial segments (≤ 2 mm 
long) were cannulated by threading them onto two stainless steel wires (25 µm) and tying the 
wires to two supports. Arteries were continuously bubbled with 95% O2 and 5 % CO2 to achieve 
a pH of 7.4 at 37°C, allowed to equilibrate for 20 minutes, and normalized prior to experiments. 
Vessel contractility was accessed by cumulative concentration-response curves (10
-9
 to 3 x 10
-5
 
M) to norepinephrine (NE). Endothelium-dependent and -independent relaxation was  assessed 
by measuring dilatory responses to cumulative concentration-response curves (10
-9
 to 3 x 10
-5 
M) 
of acetylcholine (ACh) and diethylamine NONOate (DEA-NO), respectively, in vessels pre-
contracted with NA at a concentration to achieve approximately 80% of maximal response.  
Pressure myography to assess vascular structure and mechanics 
Structural and mechanical properties of mesenteric resistance arteries were studied with a 
pressure myograph (Living Systems, Burlington, Vermont) (4,5). Mesenteric resistance arteries 
were placed in Krebs Henseleit solution, cleaned and dissected as described above. Arterial 
segments (2 to 3 mm long) were slipped onto 2 glass microcannulae, one of which was secured 
until the vessel walls were parallel, set to a pressure of 45 mmHg and allowed to equilibrate for 
30-60 min at 37 °C in a calcium-free Krebs Henseleit solution (with the addition of 10 mM 
EGTA) to eliminate myogenic tone. Arteries were gassed with a mixture of 95 % O2 and 5 % 
CO2 at 37°C. Lumen diameter and vessel thickness were measured during a pressure-diameter 
curve by increasing intraluminal pressure in 20 mmHg steps between 0 and 120 mmHg. Lumen 
diameter, cross-sectional area, media to lumen ratio (structure), stress, strain and mechanics were 
calculated as previously reported (3, 4).  
Vascular tissue preparation for Western Blotting analysis 
Total protein was extracted from vascular homogenates. Frozen aortas and mesenteric arteries 
were homogenized in 50 mM Tris-HCl (pH 7.4) lysis buffer (containing 1% Nonited P-40, 0.5% 
sodium deoxycholate, 0.1% SDS, 2 mM Na3VO4, 1 mM phenylmethylsulfonyl fluoride (PMSF), 
1µg/mL pepstatin A, 1 µg/mL leupeptin and 1 µg/mL aprotinin). Protein supernatant was 
separated by centrifugation at 13,000 x g for 10 min and pellet was discarded. The particular 
supernatant was kept at -80°C. 
Mesenteric resistance arteries were fractionated to obtain cytosol and membrane-enriched 
fractions. Frozen mesenteric resistance arteries were pulverized (TP-103 Amalgamator) in 80 ul 
of cold buffer A, which consisted of 50 mM Tris-HCl pH 7.4, 2.5 mM EDTA, 5 mM EGTA, 2 
mMNa3VO4, 1 mM PMSF, 1 g/ml leupeptin, 1 g/ml aprotinin and 1 g/ml pepstatin. The 
homogenate was centrifuged at 100,000 x g for 60 min at 4°C (ultracentrífuge Optima MAX 
(Beckman Coulter, CA, EUA), thereby isolating the cytosolic fractions in the supernatant. The 
pellet was resuspended in lysis buffer B; which consisted of lysis buffer A with the addition of 
1% triton X-100; homogenized again, and centrifuged at 13,000 g for 10 min at 4°C. The 
supernantant obtained contained the membrane fractions. The cytosolic and membrane fractions 
obtained were kept at -80°C.  
Western Blotting  
Total protein from aorta homogenates (30 µg), mesenteric arteries (25 g) and membrane-
enriched fractions (4 µg) from mesenteric arteries were used for Western Blot analysis.  Proteins 
were separated by electrophoresis on a polyacrylamide gel (10%), and transferred onto a 
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nitrocellulose membrane. Nonspecific binding sites were blocked with 5% skim milk in Tris-
buffered saline solution with 0.1% Tween for 1 hour at room temperature. Membranes were then 
incubated with specific antibodies overnight at 4°C. Antibodies were as follows: TRPM7 
(Epitomics, Abcam, Burlingame, CA); annexin-1, calpain, caveolin-1, VCAM-1, p47 phox 
(Santa Cruz Biotechnology, Dallas, Texas); phospho-JNK, phospho-ERK1/2, phospho Akt, 
phospho eNOS and eNOS (Cell Signaling, Danvers, MA). With the exception of VCAM-1 
(1:500) and TRPM7 (1:250), all the antibodies were used in a 1:1000 dilution. β-actin (1:5000 
dilution; Sigma, Oakville, ON) was used as an internal housekeeping control. After incubation 
with secondary antibodies, signals were revealed with chemiluminescence, visualized by 
autoradiography and quantified densitometrically. 
Reactive Oxygen Species (ROS) Assessment 
Vascular ROS generation was measured by lucigenin-enhanced chemiluminescence assay, with 
lucigenin as the electron acceptor and NADPH as the substrate. Aortic segments from TRPM7
+/+
 
and TRPM∆kinase mice treated with Ang II or vehicle were homogenized in assay buffer (50 
mmol/L of KH2PO4, 1 mmol/L of EGTA, and 150 mmol/L of sucrose, pH 7.4) with a glass-to-
glass homogenizer. The assay was performed with 100 µL of sample, 1.25 µL of lucigenin (5 
µmol/L), 25 µL of NADPH (0.1 mmol/L) and assay buffer to a total volume of 250 µL. 
Luminescence was measured for 20 cycles of 18 seconds each by a luminometer (Lumistar 
Galaxy, BMG Lab Technologies, Germany). Basal readings were obtained prior to the addition 
of NADPH to the assay. The reaction was initiated by the addition of the substrate. Basal and 
buffer blank values were subtracted from the NADPH-derived luminescence. Superoxide anion 
production was expressed as relative luminescence unit (RLU)/µg protein.  
Plasma hydrogen peroxide (H2O2) was assessed with Amplex Red assay kit (Molecular Probes 
by Invitrogen). H2O2 was detected spectrophotometrically in 10 µL of plasma sample. 
Absorbance was measured at multiple time points (0 to 60 min). 
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Figure legends 
 
Supplemental figure S1. Hematoxylin and eosin staining of the heart of Ang II-infused 
TRPM7
+/+
 and TRPM7∆kinase mice. Hearts were isolated from TRPM7+/+ and 
TRPM7∆kinase mice infused with vehicle or Ang II (400 ng/Kg/min). (A) Panels are 
representative photomicrographs of paraffin-embedded heart sections of 8-10 mice per group 
processed for hematoxylin and eosin staining with original magnification of x5, scale bar 200 
µm. (B) For the morphometric analysis of left ventricle (LV) wall size, the LV wall thickness 
was measured in three regions and the values were averaged. Results are presented as mean ± 
SEM of 8-10 mice per group. 
*
p<0.05 vs vehicle-infused TRPM7∆kinase mice.  
 
Supplemental figure S2. Collagen accumulation and interstitial fibrosis in the heart of Ang 
II-infused TRPM7
+/+
 and TRPM7∆kinase mice. Hearts were isolated from mice infused with 
vehicle or Ang II. Panels are representative photomicrographs of paraffin-embedded of heart 
sections of 8-9 mice per group processed for Sirius Red (A) and Masson’s trichrome (B) and, 
with original magnification of x20, scale bar 20 m. Insets depict collagen accumulation (A) and 
fibrosis (B) of the arteries.  
 
Supplemental figure S3. Aortic hypertrophy in Ang II-infused mice. Aortas were isolated 
from TRPM7
+/+
 and TRPM7∆kinase infused with vehicle or Ang II. Paraffin-embedded thoracic 
aorta sections were processed for Masson’s trichrome staining. For the morphometric analysis in 
cross-sections of aorta, the wall thickness was measured in four regions and the values were 
averaged. Upper panels, representative photomicrographs of Masson’s trichrome-stained thoracic 
aorta sections, with original magnifications x200. Bar graph, wall thickness of aortic segments. 
Results are presented as mean ± SEM of 6-7 mice per group.*P <0.05 vs. respective vehicle-
infused mice.  
 
Supplemental figure S4. Structural changes in mesenteric arteries from Ang II-infused 
TRPM7
+/+
 and TRPM7∆kinase mice. Mesenteric arteries were isolated from TRPM7+/+ and 
TRPM7∆kinase mice infused with vehicle or Ang II and mounted as pressurized systems. Lumen 
diameter (A), media cross-sectional area (B), and media lumen ratio (C) were analyzed by 
pressure myography. Mesenteric arteries were incubated in 0 Ca
2+  
physiological salt solution 
containing 10 mmol/L EGTA and were subjected to increasing levels of intraluminal pressure as 
indicated. Line graphs represent mean ± SEM of 5 mice per group. *p<0.05 vs vehicle-infused 
counterparts. 
 
Supplemental figure S5. Expression of eNOS and caveolin-1 in membrane-enriched 
vascular fractions from Ang II-infused TRPM7
+/+ 
and TRPM7∆kinase mice. Mesenteric 
arteries were isolated from TRPM7
+/+
 and TRPM7∆kinase mice infused with vehicle or Ang II. 
Protein expression of eNOS (A) and caveolin-1 (B) was analyzed in membrane-enriched 
fractions. Data are presented as the expression of eNOS (A) and caveolin-1 (B) relative to the 
expression of -actin. Results are presented as mean ±SEM of 5-9 mice per group. *p<0.05 vs 
vehicle-infused TRPM7
+/+
: 
+
p<0.05 vs Ang II-infused TRPM7
+/+
. 
 
Supplemental figure S6. Ang II effects on JNK phosphoryltion in aortas. Aortas were 
isolated from TRPM7
+/+
 and TRPM7∆kinase mice infused with vehicle or Ang II. 
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Phosphorylation levels of JNK are presented relative to expression of  actin. Upper panels, 
representative immunoblots of phospho-JNK and β-actin. Results are presented as mean ±SEM 
of 5-9 mice per group. *p<0.05 vs vehicle-infused counterparts.  
Supplemental figure S7. Vascular and systemic oxidative stress in Ang II-infused 
TRPM7
+/+
 and TRPM7∆kinase mice. Plasma, aorta, and mesenteric arteries were obtained 
from TRPM7
+/+
 and TRPM7
+/-
 mice infused with vehicle or Ang II. (A) plasma H2O2 status 
accessed by Amplex red following a 30 min reaction time; (B) time-course of Amplex red 
reaction (0 to 60 min). (C) Superoxide anion generation accessed in aorta homogenates by 
lucigenin-enhanced chemiluminescence. (D) Protein expression of p47phox analyzed in 
membrane-enriched fractions and presented as a ratio to  actin. Upper panels, representative 
immunoblots of p47phox and  actin. Bar and line graphs represent mean ± SEM of 5-14 mice 
per group. 
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